KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Net Margin (2018 - 2026)

ClearPoint Neuro's Net Margin history spans 13 years, with the latest figure at 74.79% for Q4 2025.

  • On a quarterly basis, Net Margin fell 548.0% to 74.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 69.08%, a 883.0% decrease, with the full-year FY2025 number at 69.08%, down 883.0% from a year prior.
  • Net Margin hit 74.79% in Q4 2025 for ClearPoint Neuro, down from 66.48% in the prior quarter.
  • Over the last five years, Net Margin for CLPT hit a ceiling of 54.27% in Q1 2024 and a floor of 119.85% in Q2 2023.
  • Historically, Net Margin has averaged 78.58% across 5 years, with a median of 74.27% in 2022.
  • Biggest five-year swings in Net Margin: tumbled -4651bps in 2021 and later surged 6375bps in 2024.
  • Tracing CLPT's Net Margin over 5 years: stood at 96.82% in 2021, then rose by 11bps to 86.37% in 2022, then increased by 20bps to 69.1% in 2023, then dropped by 0bps to 69.31% in 2024, then dropped by -8bps to 74.79% in 2025.
  • Business Quant data shows Net Margin for CLPT at 74.79% in Q4 2025, 66.48% in Q3 2025, and 63.34% in Q2 2025.